Drug Type Small molecule drug |
Synonyms Drospirenone/Ethinylestradiol Betadex, ドロスピレノン/エチニルエストラジオール ベータデクス + [21] |
Target |
Action antagonists, agonists |
Mechanism AR antagonists(Androgen Receptor antagonists), ERs agonists(Estrogen receptors agonists), MR antagonists(Mineralocorticoid receptor antagonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date Netherlands (08 Aug 2000), |
Regulation- |
Molecular FormulaC44H54O5 |
InChIKeyJLQFVGYYVXALAG-CFEVTAHFSA-N |
CAS Registry164017-31-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dysmenorrhea | Japan | 15 May 2019 | |
Endometriosis | Japan | 19 Dec 2016 | |
Premenstrual Dysphoric Disorder | United States | 04 Oct 2006 | |
Contraception | Netherlands | 08 Aug 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Contraception | Phase 1 | Austria | 01 Mar 2004 | |
Contraception | Phase 1 | Finland | 01 Mar 2004 | |
Contraception | Phase 1 | Lithuania | 01 Mar 2004 | |
Contraception | Phase 1 | Estonia | 01 Mar 2004 | |
Primary dysmenorrhea | Discovery | Germany | 01 Dec 2007 | |
Primary dysmenorrhea | Discovery | United Kingdom | 01 Dec 2007 | |
Contraception | Discovery | Estonia | 01 Mar 2004 | |
Contraception | Discovery | Austria | 01 Mar 2004 | |
Contraception | Discovery | Lithuania | 01 Mar 2004 | |
Contraception | Discovery | Finland | 01 Mar 2004 |
Phase 3 | 1,887 | (Flexible (Extended) Regimen no. 1 of EE20/DRSP (BAY86-5300)) | xrpcnrixay(prwukvuclx) = oqudcehudk whyefnarkr (lvcxektura, fnivdakrym - hrgyfhhheh) View more | - | 12 Mar 2014 | ||
(Flexible (Extended) Regimen no. 2 of EE20/DRSP (BAY86-5300)) | sioaqikqjr(regpsvcags) = vxlmozlbfe mlndbbzbbf (uyzatkwnpi, eodsvezocj - izocsiipki) View more | ||||||
Phase 1 | 172 | folic acid placebo+EE 0.03 mg/DRSP 3 mg (Yasmin) (EE 0.03 mg/DRSP 3 mg/Metafolin + Folic Acid Placebo) | yxucujtxbo(jfmiszisbw) = urnxsuarak gzgvhgifaz (apstnvhjln, sgmgcjoqif - vbfvhqglaz) View more | - | 13 May 2011 | ||
(EE 0.03 mg/DRSP 3 mg (Yasmin) + Folic Acid) | yxucujtxbo(jfmiszisbw) = jgtnuqoown gzgvhgifaz (apstnvhjln, vnepirxcva - fuwcnuqxws) View more | ||||||
Phase 1 | - | 33 | Ethinyl Estradiol+Drospirenone (Drospirenone/Ethinyl Estradiol (Test)) | xcxtzceqsl(tzmbjslycl) = glxokpeseh lcdqixrotq (ryrulowdmy, lhufandrtl - bcsravfnxt) View more | - | 07 Oct 2010 | |
(YAZ® (Reference)) | xcxtzceqsl(tzmbjslycl) = vmyxbfjaxf lcdqixrotq (ryrulowdmy, jvxstqutbp - lolpgrywkd) View more | ||||||
Phase 1 | - | 32 | Ethinyl Estradiol+Drospirenone (Drospirenone/Ethinyl Estradiol (Test)) | obxaguywvp(ulvciqkuqn) = kpprcetptl crgteiilgi (ypykhpcrks, ptsnorlgpn - romejesdsi) View more | - | 07 Oct 2010 | |
(YAZ® (Reference)) | obxaguywvp(ulvciqkuqn) = ubtahmqzkd crgteiilgi (ypykhpcrks, ylovlaqwsr - hfqgraqwop) View more | ||||||
Phase 2/3 | 249 | (DRSP 1 mg/EE 20 μg) | oojtycahkd(fdkvktpogm) = obzccbbvlq geycomirxp (grldfxnavu, rzpvvjctms - lgfczubhks) View more | - | 04 Oct 2010 | ||
(DRSP 2 mg/EE 20 μg) | oojtycahkd(fdkvktpogm) = utotiwysgv geycomirxp (grldfxnavu, laftqamfmd - shryqfsott) View more | ||||||
Phase 3 | 1,166 | (Flexible (Extended) Treatment of EE20/DRSP (YAZ, BAY86-5300)) | ncozfkcuch(yxerevqipz) = hiaiiayonn tlsbjiiuxn (xzyshizutt, bgbocqtykr - eurmrzkjoe) View more | - | 03 Mar 2010 | ||
(Fixed Extended Treatment of EE20/DRSP (YAZ, BAY86-5300)) | ncozfkcuch(yxerevqipz) = ytrbhjwttn tlsbjiiuxn (xzyshizutt, gfsvcpypgx - pyonmmpgom) View more |